International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today ...

Management to host conference call and webcast at 4:30 pm ET on that dayBoca Raton, Florida, April 30, 2026 (GLOBE NEWSWIRE) -- INmune Bio ...

BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric ...

Proposed combination with Clywedog Therapeutics Inc. ("Clywedog") progressing towards closing which will result in a differentiated company focusing on metabolic and autoimmune pipeline assets with mu ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Total revenue of $177 million, reflecting increase of 5 percent over first quarter 2025 driven by growth across commercial ...

Switzerland’s Seeds and Planting Material Ordinance (SR 916.151) extends even greater flexibility by enabling foreign heritage seeds to be maintained and commercialised following conservation breeding ...

When IFAT Munich opens its doors May 4–7, 2026, the world’s leading companies in environmental technology will gather in ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Search Engine Land is the industry-leading source for information about paid and organic search marketing. Our brand is driven by an authoritative team of journalists and a roster of subject-matter ...

After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...